Target intelligence / Profile preview

Endogenous stem and progenitor cell

Molecular classification
Other
01

Overview

Endogenous stem and progenitor cells refer to populations of undifferentiated or partially differentiated cells residing within tissues throughout the body; these cells have the capacity for self-renewal and can differentiate into one or more specialized cell types needed for tissue growth, maintenance, repair, and regeneration[1][2][4][5][6]. Stem cells are typically less committed than progenitor cells, with broader potential for differentiation and longer replicative capacity, whereas progenitor cells are often restricted to a narrower differentiation pathway and proliferate for a limited number of divisions[1]. These cell populations are critical for organogenesis during development, for maintaining homeostasis in adult tissues, and for regenerative responses to injury or disease. Their function is supported and regulated by specialized microenvironments termed "niches," which integrate biochemical and physical signals. Due to their broad regenerative capability and role in disease, they are a major research focus but are not a single, well-defined molecular target for drug development. This target is therefore not suitable for canonical molecular target classification and lacks a unifying specific druggability or single biomarker profile, rendering it an incorrect entry for most curated molecular target databases[1][2][3][4][5][6].

Other names
Stem cellprogenitor celladult stem cellendogenous progenitor celltissue-specific stem cellendogenous regenerative cell
02

Mechanism of action

Enhancement of endogenous repair (via growth factors); Mobilization for tissue regeneration; Modulation of inflammatory microenvironment.

03

Biological functions

Cell proliferationDifferentiationTissue regenerationHomeostasisImmune modulationWound healing
04

Disease associations

CancerInflammationAgingDegenerative diseaseCardiovascular diseaseOther (depending on tissue and cell type)
05

Safety considerations

Tumorigenicity (potential for cancerous transformation if improperly regulated)Uncontrolled fibrosis/tissue remodelingOff-target differentiation or ectopic tissue formationImmune response to manipulated cells
06

Biomarkers

CD34 (hematopoietic/endothelial progenitor markers)c-Kit (various tissue stem cells)Sca-1 (murine stem cells)Specific tissue-dependent markers such as Nestin, SFTPC (lung), or cardiac-specific markers[2][4][5]

Beyond the preview

Go deeper on Endogenous stem and progenitor cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous stem and progenitor cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call